Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival

Radical retropubic prostatectomy is considered by many centres to be the treatment of choice for men aged less than 70 years with localized prostate cancer. A rise in serum prostate-specific antigen after radical prostatectomy occurs in 10–40% of cases. This study evaluates the usefulness of novel u...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, A P, Bower, M, Smith, G L, Miano, R, Mannion, E M, Mitchell, H, Christmas, T J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363433/
https://www.ncbi.nlm.nih.gov/pubmed/11076649
http://dx.doi.org/10.1054/bjoc.2000.1474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363433/
https://www.ncbi.nlm.nih.gov/pubmed/11076649
http://dx.doi.org/10.1054/bjoc.2000.1474

Ejemplares similares